Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Novel engineering approach to developing an mRNA-encoded masked IL-12 therapeutic demonstrates potent anti-tumor activity with significantly enhanced tolerability Novel engineering approach to develop
Countdown to Moderna (MRNA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Monday, 28'th Apr 2025
Beyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
Down 36%, Is Moderna a Buy on the Dip?
06:21am, Monday, 28'th Apr 2025
In many ways, the pandemic is becoming a faded memory. With that, a major pandemic star -- biotech Moderna (MRNA -0.79%) -- also seems to be disappearing from the world's attention.
Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold
09:30am, Saturday, 26'th Apr 2025
What should investors do during a stock-market correction? One great strategy is to go shopping.
Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know
06:55pm, Friday, 25'th Apr 2025
The latest trading day saw Moderna (MRNA) settling at $27.19, representing a -0.75% change from its previous close.
Can Moderna Keep the Beat Streak Alive This Earnings Season?
01:00pm, Friday, 25'th Apr 2025
When MRNA reports first-quarter earnings, investors will likely focus on pipeline updates.
Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:08am, Thursday, 24'th Apr 2025
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Where Will Moderna Be in 5 Years?
03:10pm, Sunday, 20'th Apr 2025
In the early days of the COVID-19 pandemic, Moderna (MRNA -1.89%) was a top performer, from both a share-price and an earnings perspective. As one of the leading coronavirus vaccine companies, the bio
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
06:56pm, Thursday, 17'th Apr 2025
Moderna (MRNA) reachead $24.73 at the closing of the latest trading day, reflecting a -1.85% change compared to its last close.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Monday, 14'th Apr 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
07:00am, Thursday, 10'th Apr 2025
CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to report
Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022
07:25pm, Tuesday, 08'th Apr 2025
The first quarter of 2025 was a tough one. The S&P 500 lost 4.6%, and the Nasdaq Composite lost 10.4%.
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
07:00am, Monday, 07'th Apr 2025
CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influ
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
08:30am, Thursday, 03'rd Apr 2025
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (PFE 0.77%) and Moderna (MRNA 2.21%). These two vaccine makers mad
FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy?
04:08am, Thursday, 03'rd Apr 2025
Moderna (MRNA 2.21%) has gone through its share of ups and downs in recent years, from posting soaring coronavirus vaccine revenue a few years ago to seeing demand for that product sink in the later s
